PanGen Biotech Inc. operates as a biologics company in South Korea. It develops biosimilar products, such as EPO, recombinant factor VIII, G-CSF, etc. The company also provides CHO cell lines for proteins and monoclonal antibodies; and one-stop services ranging from producer cell line development to GMP production. In addition, it offers reagents, quantitation kits, and cell based assay systems, as well as technology transfer service. PanGen Biotech Inc. was founded in 1999 and is based in Suwon-si, South Korea.
Frequently asked questions
What sector does PanGen Biotech Inc (222110) operate in?
PanGen Biotech Inc belongs to the Energy sector and operates in the Biotechnology industry.
What is PanGen Biotech Inc (222110) current stock price?
As of the latest data, PanGen Biotech Inc stock price is ₩4,825, with a previous close of ₩4,830. PanGen Biotech Inc lost -₩5 in the last trading session, representing a -0.1% loss.
What is PanGen Biotech Inc (222110) current market capitalization?
PanGen Biotech Inc market cap is approximately 65.11 billion.
Does PanGen Biotech Inc (222110) pay dividends?
No. PanGen Biotech Inc does not pay a dividend.
What is PanGen Biotech Inc (222110) beta (volatility) score?
PanGen Biotech Inc has a beta of -0.128, indicating lower volatility than the overall market.